Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease : a pilot study
© 2024. The Author(s), under exclusive licence to Springer Nature Limited..
Acute graft-versus-host disease (aGvHD) is a serious complication of allogeneic hematopoietic stem-cell transplantation with limited treatment options. The gut microbiome plays a critical role in aGvHD pathogenesis. Fecal microbiota transplantation (FMT) has emerged as a potential therapeutic approach to restore gut microbial diversity. In this prospective pilot study, 21 patients with steroid-resistant or steroid-dependent lower gastrointestinal aGvHD received FMT in capsule form. At 28 days after the first FMT, the overall response rate was 52.4%, with 23.8% complete and 28.6% partial responses. However, sustained responses were infrequent, with only one patient remaining aGvHD-free long-term. FMT was generally well-tolerated. Microbiome analysis revealed dysbiosis in pre-FMT patient stool samples, with distinct microbial characteristics compared to donors. Following FMT, there was an increase in beneficial Clostridiales and a decrease in pathogenic Enterobacteriales. These findings highlight the potential of FMT as a treatment option for steroid-resistant aGvHD. Trial registration number NCT #03214289.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
|---|---|
| Enthalten in: |
Bone marrow transplantation - 59(2024), 3 vom: 11. März, Seite 409-416 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Youngster, Ilan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 11.03.2024 Date Revised 11.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41409-024-02198-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367032228 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367032228 | ||
| 003 | DE-627 | ||
| 005 | 20240311232108.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240114s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41409-024-02198-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1323.xml |
| 035 | |a (DE-627)NLM367032228 | ||
| 035 | |a (NLM)38212672 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Youngster, Ilan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease |b a pilot study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.03.2024 | ||
| 500 | |a Date Revised 11.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s), under exclusive licence to Springer Nature Limited. | ||
| 520 | |a Acute graft-versus-host disease (aGvHD) is a serious complication of allogeneic hematopoietic stem-cell transplantation with limited treatment options. The gut microbiome plays a critical role in aGvHD pathogenesis. Fecal microbiota transplantation (FMT) has emerged as a potential therapeutic approach to restore gut microbial diversity. In this prospective pilot study, 21 patients with steroid-resistant or steroid-dependent lower gastrointestinal aGvHD received FMT in capsule form. At 28 days after the first FMT, the overall response rate was 52.4%, with 23.8% complete and 28.6% partial responses. However, sustained responses were infrequent, with only one patient remaining aGvHD-free long-term. FMT was generally well-tolerated. Microbiome analysis revealed dysbiosis in pre-FMT patient stool samples, with distinct microbial characteristics compared to donors. Following FMT, there was an increase in beneficial Clostridiales and a decrease in pathogenic Enterobacteriales. These findings highlight the potential of FMT as a treatment option for steroid-resistant aGvHD. Trial registration number NCT #03214289 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Steroids |2 NLM | |
| 700 | 1 | |a Eshel, Adi |e verfasserin |4 aut | |
| 700 | 1 | |a Geva, Mika |e verfasserin |4 aut | |
| 700 | 1 | |a Danylesko, Ivetta |e verfasserin |4 aut | |
| 700 | 1 | |a Henig, Israel |e verfasserin |4 aut | |
| 700 | 1 | |a Zuckerman, Tsila |e verfasserin |4 aut | |
| 700 | 1 | |a Fried, Shalev |e verfasserin |4 aut | |
| 700 | 1 | |a Yerushalmi, Ronit |e verfasserin |4 aut | |
| 700 | 1 | |a Shem-Tov, Noga |e verfasserin |4 aut | |
| 700 | 1 | |a Fein, Joshua A |e verfasserin |4 aut | |
| 700 | 1 | |a Bomze, David |e verfasserin |4 aut | |
| 700 | 1 | |a Shimoni, Avichai |e verfasserin |4 aut | |
| 700 | 1 | |a Koren, Omry |e verfasserin |4 aut | |
| 700 | 1 | |a Shouval, Roni |e verfasserin |4 aut | |
| 700 | 1 | |a Nagler, Arnon |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bone marrow transplantation |d 1986 |g 59(2024), 3 vom: 11. März, Seite 409-416 |w (DE-627)NLM012638250 |x 1476-5365 |7 nnns |
| 773 | 1 | 8 | |g volume:59 |g year:2024 |g number:3 |g day:11 |g month:03 |g pages:409-416 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41409-024-02198-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 59 |j 2024 |e 3 |b 11 |c 03 |h 409-416 | ||